3 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
/LABA/ICS) - ... Dosing: 250 mcg tablet ... recommendations for the treatment ... won’t have any clinical ... #Indications #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... #Management #Pulmonary ... #LAMA #LABA #ICS ... #Guidelines
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... #differential #algorithm ... #management #cardiology ... #treatment #table ... #clinical #pharmacology